The article discusses the results of a 2014 study which showed that radical prostatectomy surgery is superior than radiotherapy for prostate cancer. Topics discussed include the National Institute for Health and Care Excellence (NICE) guidelines encouraging decision making to be based on differences in ...
Hanks GE. Radiotherapy or surgery for prostate cancer. Acta Oncol 1991;30:231-7.Hanks GE. Radiotherapy or surgery for prostate cancer? Acta Oncol 1991; 30: 231-7.Hanks GE. Radiotherapy or surgery for prostate cancer? Ten and fifteen- year results of external beam therapy. Acta Oncol 1991;...
Surgery or radiotherapy for prostate cancer? Surgery appears to be associated with better survival for men with localised disease Prostate cancer is the commonest malignancy in mal Abhay,Rane - 《Bmj British Medical Journal》 被引量: 0发表: 2014年 Radiotherapy or Surgery for Prostate Cancer? Ten...
- 《Journal of Pediatric Surgery》 被引量: 248发表: 2000年 Polymorphic variation in the androgen receptor gene: Association with risk of testicular germ cell cancer and metastatic disease Increasing incidence of testicular germ cell cancer (TGCC) is most probably related to environment and lifestyle...
Driver gene mutations that are more prevalent in metastatic, castration-resistant prostate cancer (mCRPC) than localized disease represent candidate prognostic biomarkers. We analyze 1,844 localized (1,289) or mCRPC (555) tumors and quantify the prevalen
More than 40% of men with intermediate-risk or high-risk prostate cancer will experience a biochemical recurrence after radical prostatectomy. Clinical guidelines for the management of these patients largely focus on the use of salvage radiotherapy with
Despite an intense debate over the last decades, there is no agreement today on the treatment of choice for localized prostate cancer. This is mainly due to the absence of large randomized trials comparing radical prostatectomy and radiation-based approa
The findings found no difference in disease recurrence at five years between those who received radiotherapy shortly following surgery, and those who received it later when the cancer came back. The median progression free survival rate was 85 percent for the former and 88 percent for the latter....
(553), or radiotherapy (545). The primary outcome was prostate-cancer mortality at a median of 10 years of follow-up. Secondary outcomes included the rates of disease progression, metastases, and all-cause deaths.RESULTSThere were 17 prostate-cancer–specific deaths overall: 8 in the active-...
et al. The prognostic impact of downgrading and upgrading from biopsy to radical prostatectomy among men with Gleason score 7 prostate cancer. Prostate 79, 1805–1810 (2019). PubMed Google Scholar Tilki, D. et al. Surgery vs radiotherapy in the management of biopsy gleason score 9-10 ...